The Microsoft CEO is trying to find the company’s place in the AI age while balancing the interests of nervous customers and a volatile partnership with OpenAI. 
By Austin Carr and Dina Bass

The Microsoft CEO is trying to find the company&rsquo;s place in the AI age while balancing the interests of nervous customers and a volatile partnership with OpenAI.&nbsp; By Austin Carr and Dina Bass

Listen to the most interesting reporting from this week in the world of business, finance, tech, and politics. Over the weekend, we'll share a mix of essays, reviews and other stories from Bloomberg's new Weekend Edition.  

Listen to the most interesting reporting from this week in the world of business, finance, tech, and politics. Over the weekend, we'll share a mix of essays, reviews and other stories from Bloomberg's new Weekend Edition.

Listen to the most interesting reporting from this week in the world of business, finance, tech, and politics. Over the weekend, we'll share a mix of essays, reviews and other stories from Bloomberg's new Weekend Edition.

Listen to the Story

Nadella’s Paradox: The Microsoft CEO on His AI Balancing Act

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9fd420d7-316a-4c82-a5b0-b2de012ec580/transcript

The history of nutrition science in the US suggests that MAHA would make more sense without the ‘A.’

The history of nutrition science in the US suggests that MAHA would make more sense without the &lsquo;A.&rsquo;

Were Americans Ever Really Healthy?

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/c8d08b5a-1b74-4303-a491-b31d011aa04f/transcript

A massive database of medical images is offering an unprecedented window into how diseases take hold.

A massive database of medical images is offering an unprecedented window into how diseases take hold.

What Scientists Learned Scanning The Bodies of 100,000 Brits

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b92acedd-67b3-46f4-9c5a-b31d011a2716/transcript

The shape-shifting telehealth company has spent the past year trying to cash in on GLP-1s, the hottest drug to hit weight loss in decades. It could all slip away.  By Madison Muller and Devin Leonard

The shape-shifting telehealth company&nbsp;has spent the past year trying to cash in on&nbsp;GLP-1s, the hottest drug to hit weight loss&nbsp;in decades. It could all slip away. &nbsp;By Madison Muller and Devin Leonard

Hims Won't Let Go of Its Wonder Drug

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/3111902c-5bf8-4d7f-9a24-b31a014b9be1/transcript

Nadella’s Paradox: The Microsoft CEO on His AI Balancing Act

In 1 playlist(s)

Listen to the Story

Social links

Follow podcast

Recent clips